People who live to 110 years and older have large populations of a rare type of immune cell that can kill cancer 1, finds a ...

Andrea Califano began his career as a physicist. But that's not why he's now calling cancer a quantum disease. "We're really ...

When a cell gets ready to divide, it shuts down its gene-reading machinery almost entirely. For decades, the mechanism behind ...

Fred Hutch researchers show in recent study how aggressive prostate cancer shapeshifts from a form that is treatable with ...

The study is led by Professor Shen Lin of Peking University Cancer Hospital. In the safety run‑in stage, Opamtistomig in combination with chemotherapy demonstrated encouraging efficacy signals in ...

Scientists found centromere DNA sitting at telomeres in ALT cancers, a merger of chromosome regions once thought impossible.` ...

Researchers tested experimental PCAI compounds against pancreatic cancer cells and found they had powerful anticancer effects. One leading compound blocked more than 90% of cancer cell migration, ...

Stopping tumor growth is only half the battle. Rather than killing tumor cells, many cancer therapies can only push them into ...

A new study presents a multi-layered strategy for identifying cell-surface targets that could help guide more precise ...

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on liver, cardiometabolic and oncology diseases, today announced significant ...